[24] The oncological outcome of robot-assisted partial nephrectomy in the treatment of renal cell carcinomas
Objective: To report on our oncological outcomes of robot-assisted partial nephrectomy (RPN) in the treatment of renal cell carcinoma (RCC) by a single surgeon in a single institute, as RPN has an established role in the treatment of RCC with an oncological outcome comparable to open surgery. Method...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Taylor & Francis Group
2018
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/db5d914190e94398bc86f9be09941caf |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | Objective: To report on our oncological outcomes of robot-assisted partial nephrectomy (RPN) in the treatment of renal cell carcinoma (RCC) by a single surgeon in a single institute, as RPN has an established role in the treatment of RCC with an oncological outcome comparable to open surgery. Methods: We reviewed prospectively collected data of patients who underwent RPN with a final diagnosis of RCC. RPN was used routinely in the treatment of small renal masses (<4 cm) and selectively in the treatment of larger masses (4–7 cm) at our institute. RPN was performed according to the standard protocol with a variable ischaemia time of 0–34 min. All the specimens were placed in an EndoCatch™ single-use specimen pouch. Results: In all, 335 patients underwent RPN at our institute by a single surgeon, with RCC the final diagnosis in 269 patients (80.3%). All patients but two (0.74%) had a negative margin at the initial surgery. Nine patients (3.3%) had recurrence of the RCC with a different modality of recurrence. Two patients had trocar-site recurrence, two had loco-regional recurrence with infiltration of the disease in the perinephric fat and lymph nodes, three had recurrence of the disease at the resection margin, and two had a second primary tumour in the other kidney. On multi- and univariable analyses, the tumour grade (Grade > 3), tumour stage (T1b, or T3) and tumour size (>4 cm) were associated with the likelihood of recurrence except trocar-site recurrence. Conclusion: RPN offers excellent control of RCC as shown by a low risk of recurrence (3.3%). RPN should be considered as the treatment of choice whenever it is feasible. Larger tumours, higher stage and local invasion are surrogates for recurrence. |
|---|